Galectin Therapeutics
GALT
GALT
51 hedge funds and large institutions have $5.14M invested in Galectin Therapeutics in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 50 → 51 (+1)
Holders
51
Holding in Top 10
–
Calls
$33K
Puts
$25K
Top Buyers
| 1 | +$276K | |
| 2 | +$218K | |
| 3 | +$38K | |
| 4 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
+$34.8K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$29.3K |
Top Sellers
| 1 | -$603K | |
| 2 | -$500K | |
| 3 | -$54K | |
| 4 |
CL
Croft-Leominster
Baltimore,
Maryland
|
-$42K |
| 5 |
Millennium Management
New York
|
-$29K |